Acuta Capital Partners’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.6M | Sell |
|
|||||
|
2024
Q3 | $2.27M | Sell |
|
|||||
|
2024
Q2 | $3.34M | Sell |
|
|||||
|
2024
Q1 | $9.7M | Sell |
|
|||||
|
2023
Q4 | $5.49M | Buy |
|
|||||
|
2023
Q3 | $127K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $247K | Sell |
|
|||||
|
2022
Q4 | $5.57M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $5.79M | Sell |
|
|||||
|
2020
Q4 | $18.5M | Buy |
|
|||||
|
2020
Q3 | $12.4M | Buy |
|
|||||
|
2020
Q2 | $14.8M | Sell |
|
|||||
|
2020
Q1 | $4.82M | Buy |
|